Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer
Status:
Completed
Trial end date:
2001-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients with
recurrent or progressive advanced epithelial ovarian cancer following previous paclitaxel.